Xconomy
OCTOBER 5, 2016
Organovo unveiled its plans to develop “therapeutic” tissue after showing in preclinical animal studies that bio-printed liver patches successfully grafted, formed blood vessels, and functioned normally, according to a statement today. liver transplant waiting list.
Xconomy
SEPTEMBER 9, 2016
It’s been almost two years since Organovo (NYSE: ONVO ) created a new business—using its bio-printing technology to create 3-D samples of living human liver tissue for use in testing the toxicity of pre-clinical drug candidates. We look at ourselves as a human tissues company…We’ll test your compound in our lab as a service.”.
SoCal CTO
JANUARY 5, 2011
First Principles. Steve Blank , January 25, 2010 10 Tips for Adding Game Mechanics to a Non-Gaming Service - ReadWriteStart , September 21, 2010 Startups & VCs: Learn How to Design, Market, & Eat Your Own. -
Expert insights. Personalized for you.
105 
Let's personalize your content